Public-registry trials using SerpinPC that Eichor's radar has found — 2 trials. All data below is from public sources; Eichor is not affiliated with any sponsor.
| Trial | Sponsor | Condition | Phase | Sites |
| The Efficacy and Safety of SerpinPC in Participants with Severe Hemophilia a or Moderately Severe to Severe Hemophilia B | ApcinteX Ltd | Hemophilia a | PHASE2 | 59 |
| A Study of SerpinPC in Participants with Hemophilia B (HemB) with Inhibitors | ApcinteX Ltd | Hemophilia B with Inhibitor | PHASE2 | 20 |
| First registered study | August 2019 — NCT04073498 (ApcinteX Ltd) |
| Registered studies matching this name | 5 all-time · 0 currently recruiting |
Source: ClinicalTrials.gov, the public trial registry.
Eichor generates a preliminary site-risk snapshot — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →
Other Hemophilia a drugs
← Eichor home · All tracked trials · Hemophilia a studies · Weekly briefs